UPDATE – Johnson & Johnson COVID-19 vaccine news
As of April 13, 2021, the FDA and CDC are recommending a pause in the use of the Johnson & Johnson (Janssen) COVID-19 vaccine due to a very rare and severe blood clot in some individuals who received it. Safety is a top priority for the CDC, and the use of this vaccine is on hold until these cases and analysis can be further reviewed and assessed later this week. Review this update for more information and how claims will be handled during this time.
COVID-19 billing and temporary provision updates
Last update: April 10, 2020, 8:00 a.m. CDT
We are suspending review for site of service for the surgical codes listed here through May 31, 2020.